Biome Australia (BIO) Investor presentation summary

Mission and values

• Aims to prevent disease, improve health outcomes, and make products accessible to all.

• Certified B Corporation, emphasizing responsible social and environmental practices, accountability, and transparency.

Product and market positioning

• Offers clinically-proven, condition-specific probiotics developed with leading microbiome research partners.

• Flagship products are practitioner-only, premium, and non-discounted, with a strong evidence base.

• Holds #1 position in Australian pharmacy for both adult and kids probiotics.

Financial and operational performance FY26

• International revenue reached $1.8m, up 26% from FY25, with gross margin at ~68%.

• Operating expenses were $1.82m, with net loss narrowing to $649k, approaching breakeven.

• Group gross profit was $1.21m, and international gross margin was 7pp above domestic.